Levophenacylmorphan
Clinical data | |
---|---|
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
Synonyms | Levophenacylmorphan |
CAS Number | 10061-32-2 |
PubChem (CID) | 5362482 |
ChemSpider | 16736786 |
UNII | 7Q24AL2BR2 |
ECHA InfoCard | 100.030.168 |
Chemical and physical data | |
Formula | C24H27NO2 |
Molar mass | 361.48 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Levophenacylmorphan is a morphinan derivative that acts as an opioid agonist. It has potent analgesic effects and is around 10x more potent than morphine.[1] Adverse effects associated with its use are those of the opioids as a whole, including pruritus, nausea, respiratory depression, euphoria and development of tolerance and dependence to its effects.[2]
See also
References
- ↑ MAY, E.L. & EDDY, N.B., A New Potent Synthetic Analgesic, J. Org. Chem., 24 : 294, 1959.
- ↑ Fraser HF, Isbell H. Human pharmacology and addiction liabilities of phenazocine and levophenacylmorphan. UN Bulletin on Narcotics. 1960 Issue 2
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.